Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis

被引：1

作者：

Flohr, Carsten ^{[1
,2
]}

Irvine, Alan D. ^{[3
]}

Cork, Michael J. ^{[4
,5
]}

Simpson, Eric L. ^{[6
]}

Wollenberg, Andreas ^{[7
,8
]}

Deleuran, Mette ^{[9
]}

Praestgaard, Amy ^{[10
]}

Thomas, Ryan B. ^{[11
]}

Rossi, Ana B. ^{[10
]}

机构：

[1] Kings Coll London, Dept Paediat Dermatol, St Johns Inst Dermatol, London, England

[2] Guys & St Thomas NHS Fdn Trust, London, England

[3] Trinity Coll Dublin, Clin Med, Dublin, Ireland

[4] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield Dermatol Res, Sheffield, England

[5] Sheffield Childrens Hosp, Sheffield, England

[6] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA

[7] Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergy, Munich, Germany

[8] Free Univ Brussels, Univ Hosp, Dept Dermatol, Brussels, Belgium

[9] Aarhus Univ Hosp, Aarhus, Denmark

[10] Sanofi, Cambridge, MA 02142 USA

[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 02期

关键词：

INITIAL VALIDATION;

D O I：

10.1093/bjd/ljad124

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：238 / 240

页数：3

共 50 条

[1] Dupilumab treatment improves health-related quality of life in children aged ≥6 to <12 years with severe atopic dermatitis
Irvine, Alan
Deleuran, Mette
Praestgaard, Amy
Delevry, Dimittri
Prescilla, Randy
Rossi, Ana B.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB144 - AB144
[2] Dupilumab treatment improves health-related quality of life in children aged ≥ 6 to < 12 years with severe atopic dermatitis
Irvine, A. D.
Deleuran, M.
Praestgaard, A.
Delevry, D.
Rossi, A. B.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E71 - E71
[3] Dupilumab improves signs and symptoms of severe atopic dermatitis in children aged 6-11 years with and without comorbid asthma
Prescilla, R.
Bieber, T.
Boguniewicz, M.
Siegfried, E. C.
Chen, Z.
Shumel, B.
ALLERGY, 2021, 76 : 229 - 229
[4] Dupilumab Improves Signs And Symptoms Of Severe Atopic Dermatitis In Children Aged 6-11 Years With And Without Comorbid Asthma
Boguniewicz, Mark
Sher, Lawrence
Paller, Amy
Siegfried, Elaine
Chen, Zhen
Prescilla, Randy
Shumel, Brad
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB32 - AB32
[5] DUPILUMAB TREATMENT IMPROVES HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AGED=6-<12 YEARS WITH SEVERE ATOPIC DERMATITIS
Irvine, Alan D.
Deleuran, Mette
Praestgaard, Amy
Delevry, Dimittri
Prescilla, Randy
Rossi, Ana B.
ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 60 - 60
[6] Dupilumab improves signs and symptoms of severe atopic dermatitis in children aged 6-11 years with and without comorbid allergic rhinitis
Prescilla, R.
Wollenberg, A.
Siegfried, E. C.
Chen, Z.
Abramova, A.
ALLERGY, 2021, 76 : 229 - 229
[7] Dupilumab Improves Signs And Symptoms Of Severe Atopic Dermatitis In Children Aged 6-11 Years With And Without Comorbid Allergic Rhinitis
Beck, Lisa
Wollenberg, Andreas
Paller, Amy
Siegfried, Elaine
Chen, Zhen
Abramova, Alvina
Prescilla, Randy
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB144 - AB144
[8] Benefits of treatment with dupilumab for children aged 6-11 years with severe atopic dermatitis
不详
BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : E39 - E39
[9] Dupilumab improves health-related quality of life (HRQoL) in children aged ≥6-<12 years with severe atopic dermatitis (AD)
Irvine, A. D.
Deleuran, M.
Praestgaard, A.
Delevry, D.
Levit, N. A.
Rossi, A. B.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S69 - S69
[10] Dupilumab treatment improves health-related quality of life in children aged 6 months-5 years with moderate-to-severe atopic dermatitis
Paller, Amy S.
Simpson, Eric L.
Siegfried, Elaine C.
Cork, Michael J.
Wollenberg, Andreas
Arkwright, Peter D.
Zhang, Haixin
Wang, Zhixiao
Rodriguez Marco, Ainara
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E104 - E105

← 1 2 3 4 5 →